SCHEMBL3149585

SCHEMBL3149585

CC(Cc1ccccc1-c1ccccc1)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.71
PTGER1 P34995 2/20 0.61
PTGER4 P35408 2/20 0.61
PTGER3 P43115 2/20 0.61
PTGER2 P43116 2/20 0.61
MME P08473 3/20 0.53
ACE P12821 3/20 0.53
CPA1 P15085 1/20 0.53
ACE2 Q9BYF1 1/20 0.53
KDM4E B2RXH2 1/20 0.50
APAF1 O14727 1/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
RECQL P46063 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PPARA Q07869 2/20 0.47
PPARG P37231 1/20 0.47
RXRA P19793 1/20 0.47
NR4A2 P43354 1/20 0.47
DPP4 P27487 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23189270 1.00 KMT2A (0.71) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL17051298 0.86 KMT2A (0.51) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL8520662 0.85 APAF1 (0.59) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL3141425 0.84 PTGER1 (0.54) KMT2APTGER1PTGER4PTGER3PTGER2
Bicarbonate SCHEMBL27541289 0.84 KMT2A (0.68) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL9148917 0.83 KMT2A (1.00) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL3158742 0.83 PTGER1 (0.56) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL7619239 0.83 KMT2A (0.67) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL9357720 0.82 KMT2A (0.57) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL3157543 0.81 PTGER1 (0.48) KMT2APTGER1PTGER4PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116678-B Dinuclear metallocene compound and preparation method and application thereof 中国石油化工股份有限公司 2022-06-14 CN disclosed
CN-111116788-B Polypropylene and preparation method thereof 中国石油化工股份有限公司 2022-02-01 CN disclosed
CN-111116789-B Binuclear metallocene supported catalyst and preparation method and application thereof 中国石油化工股份有限公司 2022-02-01 CN disclosed
CN-111116678-A Dinuclear metallocene compound and preparation method and application thereof 中国石油化工股份有限公司 2020-05-08 CN disclosed
CN-111116789-A Binuclear metallocene supported catalyst and preparation method and application thereof 中国石油化工股份有限公司 2020-05-08 CN disclosed
CN-111116788-A Polypropylene and preparation method thereof 中国石油化工股份有限公司 2020-05-08 CN disclosed
US-9163046-B2 Process for producing substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-10-20 US disclosed
US-20100113717-A1 Process For Producing Substituted Metallocene Compounds For Olefin Polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2010-05-06 US disclosed
US-7709670-B2 Process for producing substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-05-04 US disclosed
EP-1866322-B1 PROCESS FOR PRODUCING SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2010-02-24 EP disclosed
US-5770753-A ADDITION POLYMERIZATION CATALYST TARGOR GMBH (DE) 1998-06-23 US disclosed
EP-0705281-B1 SUPPORTED METALLOCENE CATALYST SYSTEMS FOR THE POLYMERIZATION OF OLEFINS, PREPARATION AND USE THEREOF EXXON CHEMICAL PATENTS INC (US) 1998-03-11 EP disclosed
EP-0576970-B1 Metallocenes with arylsubstituted indenyl-derivatives as ligands, process for their preparation and their use as catalysts HOECHST AG (DE) 1998-01-14 EP disclosed
EP-0790076-A2 Catalysts containing metallocenes with arylsubstituted indenyl derivatives as ligands, process and intermediates for the preparation of these metallocenes and their use HOECHST AKTIENGESELLSCHAFT (DE) 1997-08-20 EP disclosed
EP-0776913-A2 High molecular weight copolymers HOECHST AKTIENGESELLSCHAFT (DE) 1997-06-04 EP disclosed
CN-1130912-A Supported metallocene catalyst systems for polymerization of olefins, preparation and use thereof EXXON CHEMICAL PATENTS INC (US) 1996-09-11 CN disclosed
EP-0470832-B1 Biphenyl 5,5'-bis-alkanoic acid derivatives, their production and use thereof ASAHI CHEMICAL IND (JP) 1994-12-14 EP disclosed
EP-0576970-A1 Metallocenes with arylsubstituted indenyl-derivatives as ligands, process for their preparation and their use as catalysts HOECHST AKTIENGESELLSCHAFT (DE) 1994-01-05 EP disclosed
US-5136090-A Antidiabetic agents TOYO JOZO KABUSHIKI KAISHA (JP) 1992-08-04 US disclosed
EP-0470832-A2 Biphenyl 5,5'-bis-alkanoic acid derivatives, their production and use thereof ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1992-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113717-A1 Process For Producing Substituted Metallocene Compounds For Olefin Polymerization OSBP, OSBPL3, OSBP2 KMT2A 3398/4885PTGER1 4249/4885PTGER4 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.